Business News • PR NewsWire • Genovate and ScinoPharm Co-Develop Hepatitis B Drug "Livepro" -- To be Commercially Available by the End of the Year in Taiwan

Genovate and ScinoPharm Co-Develop Hepatitis B Drug "Livepro" -- To be Commercially Available by the End of the Year in Taiwan

Genovate and ScinoPharm Co-Develop Hepatitis B Drug "Livepro" -- To be Commercially Available by the End of the Year in Taiwan

TAINAN, Nov. 11, 2013 /PRNewswire/ -- Genovate Biotechnology Co. Ltd. (4130:TT) and ScinoPharm Taiwan Ltd. (1789:TT) announced today that they have jointly developed the highly potent oral generic drug Livepro (Entecavir), representing a new generation of drugs for the treatment of...

View More : http://www.prnewswire.com/news-releases/genovate-and-scinopharm-co-develop-hepatitis-b-drug-livepro----to-be-commerciall...

Releted News by prnewswire

KPMG Capital Formed to Accelerate Innovation in Data and Analytics

U.S. Veterans Honored by Encore.org's 2013 Purpose Prize

Novo relatório da GSMA mostra que a África Subsaariana lidera o mundo no crescimento e no impacto das comunicações móveis